Spearmint and caraway smell nothing alike. Both smells come from the same molecule, carvone. The atoms are identical, and only their arrangement in space differs, the way your left hand differs from your right. Chemists call the two versions mirror images.(1) (R)-carvone → spearmint / (S)-carvone → caraway In medicine, the two hands do not always behave the same way. In 1957, the German company Grünenthal began selling a drug called Contergan. Fotos: Jeanette Dietl - stock.adobe.com (Hintergrund); imago/JOKER Pregnant women took it against morning sickness. Each pill held thalidomide in both hands, half left and half right. Doctors linked the drug to serious birth defects, and it was pulled from sale in late 1961. More than 10,000 children worldwide are thought to have been affected (2). In 1979, researchers tested each hand on its own in animals. One hand had the calming effect. The other hand caused the birth defects (3). Birth defect due to thalidomide The obvious fix looks simple: sell the calming hand only. That fix fails inside the body. Within hours, each hand of thalidomide turns into the other (3, 4). A pill made only of the calming hand becomes a half-and-half mix again after the patient swallows it. Choosing the right hand at the factory would not have made the drug safe for pregnant women. Your body makes the same distinction between mirror images. It builds its proteins from one hand only. In a test tube, chemistry left to itself makes both hands in equal amounts. For more than a century, chemists had no explanation for how nature got from fifty-fifty to one hand only. On Wednesday 7 October 2026, the Royal Swedish Academy of Sciences gave the Nobel Prize in Chemistry to the two chemists who found the answer: Henri B. Kagan and Kenso Soai (5). Henri B. Kagan and Kenso Soai : Nobel Prize Chemistry 2026 Soai's experiment shows the idea in one number. In 1995, he put two teams of molecules in a flask, left hands and right hands. The teams were almost equal: 51 on one side, 49 on the other. Then the reaction started. Every new molecule came out the same hand as the molecule that helped make it, so the bigger team grew faster than the smaller one (6). Round after round, the gap got wider. In 2003, Soai ran a reaction that ended with one team only (5). Same atoms, opposite hands Your nose already knows Hold your two hands palm to palm. They match. Two hands palm to palm Now lay one on top of the other, both palms down, and the thumbs point in opposite directions. Two hands on top of each other Chemists call molecules with this property chiral, from the Greek word for hand (1). Back to the spearmint and the caraway seeds in your rye bread. Your nose tells the two carvones apart because the smell receptors inside it have a handedness of their own (1). A molecule of the wrong hand fits the receptor the way a left glove fits a right hand. Fifty-fifty in the flask, one hand in your cells Amino acids, the building blocks of proteins, also exist in two mirrored forms. The proteins in your cells use one of them. The other rarely appears in nature (2). Chemists call this homochirality, from the Greek for "same hand". Two enantiomers of a generic amino acid that are chiral When chemists ran reactions able to make both forms, the flask returned equal amounts of each. That result created two problems. The first was scientific: if chemistry left alone produces a fifty-fifty mix, something had to tip life toward one side. The second was commercial. In a medicine, only one mirror image produces the intended effect. The left-handed version of a drug may have one effect and the right-handed version another. Kagan, 1986: the output beat the input Chemists steer a reaction toward one hand with a catalyst, a helper molecule that takes part in the reaction and comes out unchanged. The working assumption was linear. A helper that is 50% pure in one hand gives a product about 50% pure in that hand. Double the purity of the helper and you double the purity of the result. In 1986, Henri Kagan and his team tested that assumption and broke it. In their reactions, the product came out purer in one hand than the helper they started with. Kagan named this deviation a non-linear effect (7). Your glove drawer shows the mechanism. Put 70 right gloves and 30 left gloves in a drawer. Pair every left glove with a right one and set the 30 pairs aside. Forty gloves stay loose, and every one of them is a right glove. Start: 70 right - 30 left = a 40-point lead for the right hand After pairing: 40 loose gloves, 40 right, 0 left = 100% right Catalyst molecules behave in a similar way. Partners of opposite hands lock together into pairs that do little or no work, and the majority hand stays free to run the reaction. In the systems chemists have studied in detail, the mixed pairs turn out to be the more stable ones (8). Soai, 1995 to 2003: a reaction that copies itself The sourdough principle A baker keeps a piece of yesterday's dough to start today's bread. The product of one batch seeds the next one. Chemists call a reaction whose product speeds up its own formation autocatalytic. Kenso Soai built a reaction in which the product molecule guides the formation of more of itself, with the same handedness. That is why the 51-to-49 mixture from the opening did not stay at 51 to 49. Each round of product served as the catalyst for the next round, and the majority hand made more of itself than the minority hand did (6). The 2003 result, one hand only, matters for a reason the Academy states plainly: Nobody other than life itself had achieved it before. Forty years from flask to Stockholm Count the years. Kagan's first decisive step dates from 1986, and the prize came in 2026. That makes 40 years. Soai's key paper is 31 years old. The committee also stayed honest about the limits. Somfai told the Associated Press that it is hard to point to one specific drug developed with these methods (7). The prize rewards an explanation of how one hand wins, and the Academy ties its pharmaceutical value to the chemists who design manufacturing reactions.. Run the same test on your CSR strategy Kagan and Soai answered one question: How a small imbalance at the start becomes total dominance at the end? A CSR plan built on proportional thinking assumes that inputs and outcomes move together, one euro of effort for one unit of impact. Chemistry showed in 1986 that this assumption fails. Here is the comparison, level by level. People Go back to thalidomide. A bottle of the harmless hand becomes a mixture once a patient swallows it. Purity at the point of production did not guarantee purity at the point of use. Your codes of conduct carry the same risk. A policy written cleanly at headquarters meets site managers, subcontractors and local incentives, and it changes form. The audit at headquarters checks the policy as written. Your workers experience the policy as applied. Kagan's result applies to boards as well. In October 2025, women held 38.2% of non-executive seats and 33.6% of all director seats in the EU's largest listed companies (9). Directive (EU) 2022/2381 set a target of 40% of non-executive seats, or 33% of all director seats, for listed companies by 30 June 2026 (10). Those figures measure the composition of the catalyst. Kagan proved that composition does not translate into the output in a straight line. No public dataset tracks how far each director shapes the final decision. Planet Agriculture shows the gain from picking the right hand. Metolachlor, a herbicide used on maize, contains mirror-image forms. Agronomists at Syngenta reported in 2002 that the S forms are about ten times more active than the R forms. The old mixed product required 2,000 to 3,000 grams per hectare. The S-enriched version, S-metolachlor, requires 1,200 to 1,900 grams for the same weed control (11). Low end: 1,200 / 2,000 = 0.60, so 40% less active ingredient High end: 1,900 / 3,000 = 0.63, so approximately 37% less. A farmer who switched puts approximately 37 to 40% less active ingredient on each hectare. Now the complication. Swiss researchers tracked metolachlor in Lake Baldegg from 1997 to 2001. The chemical fingerprint of the residues shifted to the new S product within a few years. Their data did not show lower total concentrations in the lake, because heavy rain during the spraying seasons made the year-to-year comparison unreliable (12). The dose reduction comes from the manufacturer's own agronomists. The independent lake data confirms the switch. It does not confirm the environmental benefit. Profit The classic industrial route to a single-hand molecule makes both hands and separates them afterwards. Run the arithmetic on that route. Reaction output: 50% right hand + 50% wrong hand Maximum usable yield: 50% Per 1 kg sold: at least 1 kg of the wrong hand, unless recycled You pay for the raw materials, solvents, energy and disposal of a molecule nobody buys. That waste sits on top of an already heavy load. Pharmaceutical manufacturing generates approximately 25 to 100 kilograms of waste for every kilogram of active ingredient, a range first set out through the E factor that the chemist Roger Sheldon introduced (13). Sheldon described one fine-chemical process in which the cost of disposing of its chromium waste approached the sales value of the product itself. CSR budgets carry the same blind spot. A sustainability line reported as spend counts the inputs. It says nothing about the share of that spend that produces the intended result, and nothing about the share that ends up as the corporate equivalent of the wrong hand. Why this chemistry earned the Nobel Prize For more than a century, chemists knew that life uses one hand and had no chemical mechanism that explained how one hand wins from an almost even start. Kagan showed that the purity of the output does not have to follow the purity of the input. Soai showed that a product able to copy itself turns a small lead into total dominance. The two results give origin-of-life research a working mechanism and give pharmaceutical chemists principles for designing reactions. Four chemistry prizes, one thread 2023, quantum dots (Bawendi, Brus and Ekimov): the size of a nanoparticle sets its colour. 2024, proteins (Baker, Hassabis and Jumper): computational design of new proteins and prediction of the shape of existing ones, the shape that sets each protein's job. 2025, metal-organic frameworks (Kitagawa, Robson and Yaghi): designed porous structures that trap large quantities of gas, with potential use in capturing greenhouse gases. 2026, mirror-image chemistry (Kagan and Soai): the handedness of a molecule decides what it does in your body and in a maize field. Look at what links the four. Each prize rewarded a discovery about the way matter is arranged. In a quantum dot, size sets the colour. A protein’s fold decides its job. The pattern of holes in a framework decides which gas it traps. With carvone, the hand decides between mint and caraway. Same atoms, different arrangement, different result. Now hold a CSRD report next to that list. The European Sustainability Reporting Standards ask mainly for totals, such as gross greenhouse gas emissions in tonnes of CO2 equivalent and the number of employees. A total works like a kitchen scale. Think back to the metolachlor case. A farm record shows how many grams of herbicide the farmer sprayed per hectare. It does not show whether the farmer used the old fifty-fifty mix or the product enriched in the active hand. A CSRD report works the same way. It counts how much a company emits, how many people it employs and how much it spends. It says far less about how those tonnes, people and euros are arranged inside the business. (1) Russell, G.F. and Hills, J.I., Odor differences between enantiomeric isomers, Science, 1971. https://pubmed.ncbi.nlm.nih.gov/5573954/ (2) CNN, German maker of thalidomide apologizes, 1 September 2012. https://edition.cnn.com/2012/09/01/health/germany-thalidomide-apology (3) Tokunaga, E., Yamamoto, T., Ito, E. and Shibata, N., Understanding the thalidomide chirality in biological processes, Scientific Reports, 20 November 2018. https://doi.org/10.1038/s41598-018-35457-6 (4) Proceedings of the National Academy of Sciences, Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs, 2015. (5) Royal Swedish Academy of Sciences, Press release: The Nobel Prize in Chemistry 2026, 7 October 2026. https://www.nobelprize.org/prizes/chemistry/2026/press-release/ (6) Soai, K., Shibata, T., Morioka, H. and Choji, K., Asymmetric autocatalysis and amplification of enantiomeric excess of a chiral molecule, Nature 378, 767, 1995. https://www.doi.org/10.1038/378767A0 (7) Associated Press, via Anchorage Daily News, Nobel Prize in chemistry awarded to Kagan and Soai, 7 October 2026. https://www.adn.com/nation-world/2026/10/07/nobel-prize-in-chemistry-awarded-to-kagan-and-soai-for-untangling-mirror-images-in-molecules/ (8) In situ mass spectrometric and kinetic investigations of Soai's asymmetric autocatalysis, Chemistry: A European Journal, 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7756584 (9) European Institute for Gender Equality, Gender balance in decision-making: largest listed companies, data for October 2025, published 2026. https://eige.europa.eu/sites/default/files/documents/202602335_pdf_mh0126044enn_002.pdf (10) European Parliament and Council, Directive (EU) 2022/2381 on improving the gender balance among directors of listed companies, 23 November 2022. https://eur-lex.europa.eu/eli/dir/2022/2381/oj (11) Roy, C., Guggiari, F. and Compagnon, J.M. (Syngenta Agro France), S-metolachlor, maize, sorghum and sunflower herbicide, 2002, record in FAO AGRIS. https://agris.fao.org/search/en/records/6472391b53aa8c896302c96f (12) Roy, C., Guggiari, F. and Compagnon, J.M. (Syngenta Agro France), S-metolachlor, maize, sorghum and sunflower herbicide, 2002, record in FAO AGRIS. https://agris.fao.org/search/en/records/6472391b53aa8c896302c96f (13) Sheldon, R.A., The E factor 25 years on: the rise of green chemistry and sustainability, Green Chemistry, 2017. https://pubs.rsc.org/en/content/articlehtml/2017/gc/c6gc02157c

Nobel season is our favourite week of the year. Six announcements, six chances to watch the world agree for a moment that evidence matters. On Monday 5 October 2026, Karl Deisseroth, Peter Hegemann, and Georg Nagel won the Nobel Prize in Medicine for their discoveries concerning light-gated ion channels and optogenetics (1). Karl Deisseroth, Peter Hegemann, Georg Nagel: Nobel Prize 2026 in Medecine To be simple, they gave science a light switch for individual brain cells. Shine blue light and a chosen type of neuron fires. Shine yellow light on a different protein and the neuron goes silent. The response comes within milliseconds, in a living, moving animal. Light switch for brain cells (created by AI) I trained as a physical and analytical chemist. The first lesson of my discipline is the distance between a signal and a cause. This prize rewards the people who closed that distance for the brain. Most sustainability reports I read have not started. Below, I explain the science in plain words. Then I hold it next to the way companies run CSR as a business model. Decades of watching Before explaining what this Nobel Prize is all about, let's agree on the definition of these two concepts: Correlation A correlation means two things change together. Causation Causation means changing one makes the other change. Ice cream sales and drownings rise together every summer. Nobody bans ice cream to save swimmers, because a third factor, hot weather, drives both. For most of modern neuroscience, researchers recorded the brain with four main tools: Electrodes that record electrical activity, Brain imaging, Lesions that destroy an area, and Drugs told them which areas lit up during fear, memory or movement. According to The Nobel Committee, these methods established correlations between brain activity and perception, movement, emotion and cognition (2). Each tool hits a limit before it reaches cause. Recording and imaging only watch. A scan shows the amygdala active while a person feels fear. That activity might produce the fear, follow from it, or run alongside it, driven by something else. Watching does not tell you which. Lesions and drugs intervene, but bluntly. Destroy an area and the behaviour disappears, yet that area holds many cell types mixed together, and the lesion removed all of them. A drug spreads to many cell types as well, and it acts far slower than neurons, which signal in thousandths of a second. Researchers learned that something in the region mattered. Which cells, and at which moment, stayed out of reach. Take your electricity bill. Your smart meter shows a spike every evening at seven. The meter will not tell you whether the oven, the heat pump or the gaming PC in your son’s bedroom caused it. You find out one way. You switch off one appliance at a time and watch the number. Neuroscientists had no such switch. Neurons of different types sit packed together, and neighbouring cells often drive opposite functions. Francis Crick wrote in 1999 that the ideal tool to control them would be light, and called his own idea "rather far-fetched" (3). Francis Crick The answer came from algae Chlamydomonas is a green alga made of a single cell, and it swims toward light. In 1991, Peter Hegemann and his colleague Harald Harz measured the tiny electric current (4) that starts that swim. It switched on within millionths of a second after a flash of light. Cells usually pass a signal along a chain of chemical steps, and chains take time. Hegemann concluded there was no chain. One single molecule had to catch the light and let the current through. Georg Nagel proved it. In 2002 and 2003, he took the algae gene for that molecule and placed it in frog eggs and in human kidney cells grown in the lab. When the team shone light on those cells, an electric current flowed. One molecule did both jobs: it sensed the light and opened a gate in the cell wall for electric charge. The team named it channelrhodopsin (5,6). Brain cells talk to each other with electric signals. In 2005, Karl Deisseroth’s team at Stanford put the algae gene into rat brain cells grown in a dish. Blue light made the cells fire on command, one signal per flash, as fast as the light blinked (7). Earlier teams tried lasers and dyes (2), which damaged the cells. Others built systems from several genes at once, and those reacted too slowly to keep up with a brain signal. The 2005 success then hung on a small detail. This algae molecule needs a helper, retinal, a form of vitamin A, to catch light. Nagel noticed that brain cells already carry enough of it, so nobody had to inject any (7). Count the years. The algae measurement came out in 1991. The Nobel call came in 2026. That is 35 years of research on pond algae with no product and no revenue line. How many projects in your R&D budget would survive 35 years of that? What the switch revealed Once researchers held a switch for specific cells, the brain stopped looking like a set of regions and started looking like a set of circuits. Three results matter for anyone who runs an organisation. In 2012, Stephan Lammel, Karl Deisseroth, Robert Malenka and colleagues showed that dopamine neurons in the same small brain region drive opposite states, reward in one case and aversion in the other, depending on which inputs reach them (8). In 2013, Steve Ramirez and colleagues in Susumu Tonegawa’s laboratory at MIT created a false memory. Mice froze in fear in a room where nothing bad had ever happened to them (9). In 2021, José-Alain Sahel, Botond Roska and colleagues reported that a blind patient with retinitis pigmentosa, treated with an optogenetic gene therapy and engineered goggles, regained enough vision to locate high-contrast objects on a table. The result covers one patient and partial vision, after decades of work. Several clinical trials are now under way (10, 2). Hold your CSR report up to the same light Companies have the brain’s old problem. Activity shows up everywhere, and causes show up nowhere on the dashboard. Here is the comparison, level by level. People An annual engagement survey records the whole organisation at once, the way an electrode on the scalp records the whole brain. Scores drop in one department. The cause sits somewhere among the manager, the shift pattern, the pay grid and the open-plan floor, and the survey will not say where. The Lammel result applies here. Two teams on the same floor respond in opposite directions to the same policy. A company-wide wellbeing programme averages them into a flat line. Which of your People initiatives have you ever switched off at one site and kept at another, to see what changed? Planet The environmental disclosure platform, found in 2021 that supply chain emissions average 11.4 times a company’s own operational emissions (11). In a 2023 report, approximately 41% of responding companies disclosed at least one category of those supply chain emissions (12). Run the arithmetic for an average company. Operational emissions equal 1 unit, supply chain emissions equal 11.4 units, total equals 12.4. A report that covers operations alone covers approximately 8% of the footprint. Pre-2005 neuroscience recorded the surface of the skull. The Planet equivalent is a carbon report that stops at the factory gate. Which supplier category would you target first if you had to prove a reduction, not estimate one? Profit Optogenetics answers two questions about any cell. Switch it on: is it sufficient to produce the behaviour? Switch it off: is it necessary? Apply the same two tests to each line of your CSR budget. Turn the programme off. Does revenue move, does risk move, does anyone outside the communications team notice? The Ramirez experiment has a commercial twin. Greenwashing plants a memory of virtue in customers who never saw anything green happen. The European Union has noticed. Directive (EU) 2024/825 on empowering consumers for the green transition bans generic environmental claims without recognised proof, and member states apply it from 27 September 2026. Ten days ago, the false memory became a legal liability. Why optogenetics earned a Nobel Prize The Nobel Prize in Physiology or Medicine rewards, in the Nobel Assembly’s words, the most important discoveries for the benefit of humankind. For more than a century, brain science watched the brain and guessed at causes. Optogenetics lets researchers test them. They switch a chosen group of cells on and see whether a behaviour appears, then switch it off and see whether it disappears. A guess becomes proof. The method also left the lab bench of its inventors. Laboratories around the world now use it, as the Nobel Assembly noted on announcement day. It has given one blind patient partial sight, and several clinical trials are now under way. Researchers also hope it will make cochlear implants more precise than today’s electrical devices. None of it began as a plan to cure anything. A few scientists wanted to know how a single-celled alga finds the light. Harz and Hegemann published their algae recording in Nature in 1991. Thirty-five years later, Stockholm called. Conclusion This prize completes a pattern. 2023, mRNA (Karikó and Weissman): messenger RNA delivers instructions to make a protein on demand. Their key finding was a small chemical change to the RNA that switches off the immune system's false alarm against it. Without that change, the vaccine triggers inflammation. With it, the instruction gets through. 2024, microRNA (Ambros and Ruvkun): tiny RNA molecules silence specific genes. Every cell carries the same DNA, and microRNAs decide which instructions a muscle cell ignores and which a brain cell ignores. 2025, regulatory T cells (Sakaguchi, Brunkow and Ramsdell): these cells and the Foxp3 gene act as brakes on the immune system. Remove the brake and the body attacks itself, causing autoimmune disease. 2026, optogenetics (Deisseroth, Hegemann and Nagel): a light-triggered switch that turns chosen neurons on or off within milliseconds. Companies invest heavily in growth engines and rarely in their own off switches. Few have a governance mechanism that stops a programme when evidence shows it fails, or a brake that catches a strategy before it damages the business. Four Nobel committees in a row rewarded control systems, while most boards still reward expansion. (1) https://www.nobelprize.org/prizes/medicine/2026/press-release/ (2) https://www.nobelprize.org/prizes/medicine/2026/advanced-information/ (3) https://royalsocietypublishing.org/rstb/article-abstract/354/1392/2021/19541/The-impact-of-molecular-biology-on-neuroscience?redirectedFrom=fulltext (4) https://www.nature.com/articles/351489a0 (5) https://www.science.org/doi/10.1126/science.1072068 (6) https://www.pnas.org/doi/full/10.1073/pnas.1936192100 (7) https://www.nature.com/articles/nn1525 (8) https://www.nature.com/articles/nature11527 (9) https://www.science.org/doi/10.1126/science.1239073 (10) https://www.nature.com/articles/s41591-021-01351-4 (11) https://www.cdp.net/es/press-releases/environmental-supply-chain-risks-to-cost-companies-120-billion-by-2026 (12) https://www.hlc.com/en/publications/cdp-reports-limited-progress-on-scope-3-nature-related-disclosure

Pink October campaign Every October, someone will ask you to buy something pink. A shampoo. A yogurt. A candle. A bucket of chicken. Part of the price goes to the fight against breast cancer, and the ribbon on the label tells you whose side the company is on. Nobody will ask what is inside the bottle. Last October I opened a talk with a photograph of a man in a suit. Under the photo I wrote his profile: male, white, 70 kilos, 25 to 40 years old, stable hormones, no chance of pregnancy. Medicine calls him the reference patient. Drugs, devices and safety limits were built around his body. The women in that room had spent their whole lives being measured against him. Reference patient Forty-one Octobers What Pink October is If you have never heard of Pink October, here is the short version. Every October, charities, hospitals, brands and governments turn things pink. The message to women is simple: get screened for breast cancer, and give money to fight it. The month started in the United States in October 1985. Its founders were the American Cancer Society and the pharmaceutical arm of Imperial Chemical Industries, at the time one of the largest chemical companies in the world. That arm later became part of AstraZeneca, a major seller of breast cancer drugs. From day one, the goal was to promote mammography. The ribbon came seven years later. In 1992, Evelyn Lauder of Estée Lauder and Alexandra Penney, editor of Self magazine, handed out 1.5 million pink ribbons in Estée Lauder stores across New York [1]. By the end of the decade, the movement was global. Brest cancer awareness month A chemical company helped start the month. A cosmetics company gave it its colour. Keep both facts in mind for the rest of this article. So what did 41 years of pink buy? Real progress on one number. In high-income countries, 83% of women diagnosed with breast cancer survive. In low-income countries, more than half of the women diagnosed die from it. [3] Belgium is one of seven countries meeting the WHO target of a 2.5% drop in breast cancer deaths every year. Screening saves lives. At the same time, globally, 2.3 million women were diagnosed in 2022 and 670,000 died. In half of the countries examined, the rate of new cases rose by 1 to 5% a year. By 2050, new cases are projected to climb by 38% and deaths by 68%. Screening finds the cancer. It does nothing to stop the cancer from starting. To prevent cancer from happening , you need to do prevention. Larousse defines prevention as the set of measures taken to prevent a danger, a risk or a harm, and the organisation in charge of putting those measures in place. That gives two halves: the measures, and someone answerable for them. Now the official kit. The European Code Against Cancer, 5th edition, published in October 2025 "14 ways you can help prevent cancer".[5] Every recommendation incriminates you. Do not smoke. Avoid alcohol. Breastfeed your baby. Take part in screening. At work, inform yourself about cancer-causing factors and ask your employer to protect you. Against air pollution, take public transport. The chemicals in your shampoo, your cosmetics and your food packaging appear in none of the fourteen. To be fair, this edition adds 14 recommendations for policy-makers, a first in the code's history. They cover tobacco taxes, alcohol prices, air quality limits and industrial emissions. Consumer product chemistry is missing there too. Industry appears once, as a risk to manage: governments are asked to protect the recommendations against undue industry interference. So the Larousse definition is half met. The measures exist. The organisation in charge of them turns out to be the woman herself, with fourteen tasks on her list, while the companies that formulate what she puts on her skin have none. In 2010, Barbara Brenner, then head of the watchdog group Breast Cancer Action [6], said in public that the world did not need any more awareness. Sixteen Octobers later, awareness is the one thing Pink October produces in surplus. Barbara Brenner Read the ribbon as a business model The parallel Let's forget that Pink October is about cancer awareness, and let's see it as a simple business model. A company sells more of its product in October. A slice of each sale goes to a charity. The more it sells, the more it gives, and the better it looks. Revenue, donation and reputation all grow with volume. In most European countries, the tax office then gives back part of the gift. The gesture is generous, deductible and photogenic. Now look at what stays the same: the product, the formula, the supplier and the volume. Philanthropy is kindness with a tax receipt. A CSR strategy works on the business model itself. It changes how the company earns its money and who pays when the product causes harm. A company that gives 50 cents per pink bucket has a charity budget. A company paid for the result instead of the volume has a strategy. Philantropy is not a CSR strategy Since 2004, the UN Industrial Development Organization has promoted a different model, called Chemical Leasing. The supplier stops selling tonnes. It sells the function the chemical performs: parts cleaned, surfaces coated, kilos of laundry washed. The customer pays for the result, and every extra litre of chemical becomes a cost for the supplier instead of revenue. The supplier now has a direct reason to use less, and to know exactly what it puts in. In our previous article [7], we showed how Signify, Michelin and Rolls-Royce sell light, kilometres and flying hours, so the seller pays for every unit that fails. Pink October works the other way round. The seller earns goodwill on every unit sold. If anything inside the product causes harm, the bill reaches the woman and her health system years later, long after the ribbon is in the bin. Hold those two models side by side. One rewards selling more. The other rewards needing less. Let see now what that means, pillar by pillar. The ribbon goes on the outside ENVIRONMENT Companies report carbon. Tonnes of CO2, scope 1, scope 2, a reduction target for 2030. The chemistry of what they sell gets a paragraph, if it gets one at all. Start with a word most consumers never learned: endocrine disruptor. Your body runs on hormones. A hormone is a chemical message that tells a cell what to do. An endocrine disruptor is a substance that interferes with that message. It copies the hormone, it blocks the hormone, or it scrambles the signal. Breast cancer is often hormone-driven. You see where this goes. The cost of these chemicals is no secret. In 2016, a team led by Leonardo Trasande [8] calculated that exposure to endocrine disrupting chemicals costs the European Union a median of €163 billion a year, 1.28% of EU GDP. Divide by 365 and you get approximately €447 million a day. The authors priced only the chemicals with the strongest evidence and said a wider analysis would push the bill higher. Read the list of diseases they put a price on. IQ loss, autism, ADHD, endometriosis, fibroids, obesity, diabetes, undescended testicles, male infertility, and deaths linked to low testosterone. Breast cancer is not on it. The most quoted euro figure on endocrine disruptors leaves out the disease Pink October was built for. So the real bill is higher than €163 billion. How much higher? We do not know. Let's talk about Phtalates. Phtalates Phthalates are chemicals that make plastic soft and help fragrances last. The link between phthalates and breast cancer is not settled. Studies disagree. Some find nothing. Hold that thought. A Danish study followed 1.12 million women over almost 10 million woman-years. Most phthalate exposures showed no link to breast cancer. Women with high cumulative exposure to one phthalate, dibutyl phthalate, through medicines formulated with it, had approximately double the rate of hormone-sensitive breast cancer. Lower doses showed no link.[9] One line in the funding section deserves a second look: part of the money for that study came from Susan G. Komen for the Cure. Remember the name. A narrow finding. Also the exact kind of finding a risk committee exists to price. A board that waits for certainty on a chemical in its product line is a board that has decided to let a regulator set the timing. Brussels already set it. On 31 March 2023, the European Commission published a regulation that created new hazard classes for endocrine disruptors under the EU rules on classification and labelling, known as CLP. [10] Substances already on the market must be classified under the new rules by 1 November 2026. Mixtures already on the market follow by 1 May 2028 (Dutch Board for the Authorisation of Plant Protection Products and Biocides). Count from April 2023 to October 2026 and industry had approximately 43 months of notice. Forty-three months. How many board meetings is that? How many of them had "endocrine disruptors" on the agenda? Go back to the two business models. A company that sells volume buys ingredients on price and asks the supplier for a safety data sheet. A supplier paid for the function carries the cost of every gram it adds, so it has every reason to know what each gram does. One model reads the hazard data at the deadline. The other reads it at the design stage. Take your best-selling product and print its list of ingredients. For each ingredient, write down two things: who checked whether it disrupts hormones under the new EU rules, and on what date. If you leave both blanks empty, your company has no idea whether that product will need a new formula after 1 November. A pink ribbon on a product you never checked costs you nothing in October, but it may cost you a reformulation, new labels and your reputation later. The threshold was built for someone else SOCIAL Go back to the man in the suit. In 1977, the US Food and Drug Administration issued a guideline that kept most women of childbearing age out of early clinical research. The FDA formally reversed it in 1993.[11] Sixteen years. Many drugs approved before the early 1990s, some still prescribed today, were tested in trials where women were missing or barely present.[12] The reference patient did not stay in the pharmacy. He moved into the medical devices too. During the pandemic, doctors relied on pulse oximeters, the small clip on your finger that reads the oxygen in your blood. In December 2020, researchers at the University of Michigan compared those readings with blood tests. When the clip showed a healthy 92 to 96%, the blood test showed dangerously low oxygen in 11.7% of readings from Black patients, against 3.6% from white patients.[13] The gap is approximately 3.2 times. The device worked. It worked for the body it was calibrated on. Oximeter Chemical safety follows the same logic. A safety limit tells you how much of a substance a body tolerates. Which body? The phthalate research hints at the answer. In a US study of five ethnic groups, the risk of breast cancer among Native Hawaiian women rose with exposure to eight of ten phthalates measured. The only earlier study of its kind had found nothing, in a group of mostly white women.[14] Missing data does not mean missing risk. It means nobody looked. Here the business model matters again. A model that sells volume needs one average customer, and the average customer looks a lot like the man in the suit. A model paid for results has to deliver for every customer it serves, including the ones furthest from the average. Those customers are where the failures show up first, and where the seller pays first. My position is simple. Set the threshold on the most exposed body, and every other body is protected by default. Set it on the reference patient, and the people least like him carry the risk without ever being told. Whose body set the safety limit for the product you sell? Do you know? Does your supplier know? The person who made the promise pays GOVERNANCE In April 2010, KFC turned its buckets pink. [15] For every pink bucket, restaurant operators donated 50 cents to Susan G. Komen for the Cure. The campaign raised $4.2 million. At 50 cents a bucket, that is approximately 8.4 million buckets of chicken (4,200,000 ÷ 0.50). KFC Pink Campaign Breast Cancer Action called it pink washing, a term the group coined for companies that wrap themselves in the ribbon while selling products linked to the disease.[16] KFC answered that its ads featured the grilled chicken. One part of the money paid for research on what women are exposed to. Another part came from a bucket nobody audited. That bucket is the volume model in its purest form. The donation grew with every bucket sold. Nothing in the contract asked what was in the bucket. CSRD now applies only to companies with more than 1,000 employees and more than €450 million in turnover. Approximately 90% of the companies previously covered are now out [17]. Most of the companies I work with earn between €50 million and €500 million a year. Under €450 million, the reporting duty is gone. Fewer reports. Fewer questions. Fewer pages where a phthalate would ever appear. Now the irony. The duty to report shrank in February. The duty to classify grows on 1 November. Two different teams own those two duties. The sustainability team writes the report. Regulatory affairs reads the supplier's safety data sheet. Which document does your board read? A product as a service-based contract answers that question without a committee. The party that chose the ingredient is the party that pays when the ingredient becomes a problem. No report cycle sits between the decision and the bill. Run the math. Profit equals revenue minus cost. A pink campaign books revenue in October. A forced reformulation books cost later, on a deadline written in Brussels in 2023. The marketing team takes credit for the first number. Who takes the second? Climate has its own version. A company publishes a carbon target, plants trees, and buys offsets, while its product line stays the same. Same logic, different colour. Governance exists to close that gap. In ESG language, governance means board committees, audits, disclosure rules, and sustainability reports. All of that machinery has one job: force someone to answer for a risk they created. So look at what happened to the machinery this year. In February 2026, the EU approved the Omnibus package. Mandatory sustainability reporting under The math of profits Two numbers belong on your next board agenda. The revenue from your pink campaign this month. The cost of replacing every ingredient in that pink product that meets the new endocrine disruptor criteria. If the second number does not exist yet, your C-suite/ board has approved a campaign without knowing what it is selling. Who on your C-suite/Board signed off on the pink packaging? Who signed off on the formula inside it? Is it the same person? Detection is a budget line. Prevention is a design choice. Pink October and recycling share a business model. Both clean up after the product. Neither touches the product. Recycling sorts the waste after the sale. Screening finds the tumour after the exposure. Both deserve funding. Neither one changes what goes into the bottle. Pink October asks women to check their bodies. Fair enough. Checking works. A campaign that only asks the patient to act leaves the product off the hook. The woman gets the mammogram. The bottle gets the ribbon. As a physical chemist, I read the label before I read the slogan. Earlier I asked you to keep the mixed evidence on phthalates in mind. Here is why. Mixed evidence is the normal state of chemical risk, and Brussels has stopped waiting for it to clear. The new CLP rules include a category called "suspected endocrine disruptors for human health," created for exactly this situation [18]. A board that hides behind "the science is not settled" will find that the regulation already has a box for unsettled science. The companies that get ahead of it will be the ones whose boards stopped asking "are we sure it causes harm?" and started asking "what will it cost us when the classification says it might?" Forty-one years of awareness taught women to check their bodies. A contract that makes the seller pay for what it puts in teaches the seller to check its formula. Pink October ends on 31 October. The EU Classification, Labelling and Packaging deadline for substances already on the market falls on 1 November 2026. [1] https://aparte.mu/en/article/pink-october-40-ans-de-lutte-contre-le-cancer-du-sein [2] Gayle A. Sulik, Pink Ribbon Blues : How Breast Cancer Culture Undermines Women's Health, 424 pages, published 28 October 2010. [3] https://news.un.org/en/story/2025/02/1160391 [4] https://ecommons.aku.edu/eastafrica_fhs_mc_gen_surg/142/ [5] https://cancer-code-europe.iarc.who.int/wp-content/uploads/2025/10/European-Code-Against-Cancer-5th-edition.pdf [6] https://en.wikipedia.org/wiki/Breast_Cancer_Action [7] https://www.science-by-trianon.com/post/the-companies-that-got-richer-by-never-selling-you-their-product [8] https://pmc.ncbi.nlm.nih.gov/articles/PMC5244983/ [9] https://ascopubs.org/doi/10.1200/JCO.18.02202 [10] https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32023R0707 [11] https://orwh.od.nih.gov/toolkit/recruitment/history [12] https://www.medidata.com/en/life-science-resources/medidata-blog/women-in-clinical-trials-history/ [13] https://pmc.ncbi.nlm.nih.gov/articles/PMC7808260/ [14] https://link.springer.com/article/10.1186/s13058-021-01419-6 [15] https://www.qsrweb.com/news/kfc-campaign-raises-more-than-4-million-for-breast-cancer-research/ [16] https://www.npr.org/sections/health-shots/2010/04/breast_cancer_awareness_in_a_b.html [17] https://bpma.co.uk/eu-gives-final-approval-for-csrd-and-csddd-simplification/ [18] https://dguv.de/ifa/fachinfos/endokrine-disruptoren/regulatorik/index-2.jsp

Ownership looks like the win. Buy the machine. Own the asset. Put in the balance sheet and call it a strategy. I have sat across the table from boards that repeat this logic for twenty years, and I have watched what that logic cost them five years later. The buyer owns the failure. The buyers owns the waste. the buyer owns the disposal cost nobody put in the brochure. Ownership was never the prize. It is the risk, quietly handed to whoever signed the check. A different model has been running for decades, mostly ignored by companies who think sustainability strategy starts with a carbon report. I have worked inside enough of these deals to know that the technology was never the obstacle. It is called "Product as a Service". You do not buy the light, you buy the illumination. You do not buy the tire, you buy the kilometre. You do not buy the jet engine, you buy the flying hour. The maker keeps the asset and keeps the failure cost too. The contracts are simple to write. Getting a board to let go of the word "own" is the part that take years. Every circular economy strategy on the market today talks about what to do with waste once it exists. Upcycle it, downcycle it, recycle it, offset it, report it, hand it to a specialist who takes it off your books and out of your scope 3 inventory. None of that touches the actual lever, which sits upstream of all of it: produce less in the first place, design product sustainable buy design. A service model does that without a mandate or a task force, because the seller now pays for every unit that fails, breaks, or gets thrown away. Waste stops being the customer's later problem and becomes the seller's cost line on this quarter report. That is not circularity bolted on after the design is finished. That is sustainability built into the product before the product exists. That is sustainability by design. That single shift changes who cares about the waste, who trains the workforce, and who answers for what breaks. Here what evidence shows, pillar by pillar. Electronic waste The seller now owns the waste Environment Signify, Philips lighting brand, runs a model called Light as a service [1]. The customer pays for illumination, priced per lux delivered to the room, not per appliance installed. Signify keeps the appliances (the overhead panels, high warehouse lights, and sensors) keeps the maintenance, and keeps the responsibility for what happens to the bulbs once they wear out. The steel and mining company ArcelorMittal at its Sagunto site in Spain [2], moved to this model and had its lighting upgraded, maintained and eventually recycled by Signify rather than dumped by the client. Switching a building to connected LED lighting under this kind of contract cuts lighting-related electricity use by up to 70% percent. Here is the catch. This model asks a company to swap a large upfront purchase for a smaller recurring payment. That sounds easier, but a finance department built around depreciation schedules, it is not automatically easier. It changes how the deal sits on the books, and some finance teams resist that change harder than they resist the sustainability pitch itself. The obstacle to circularity is not the physics. It is accounting. Regulation is closing that gap whether finance teams like it or not. The EU Ecodesign for Sustainable Products Regulation [3] entered into force in July 2024. It introduces the Digital Product Passport, a record that will travel with a product and document its materials, its durability, and what should happen to it when its working life ends. The requirements roll out sector by sector through 2030. A company that already tracks a product's full life cycle because it is running a service model will fill out that passport with ease. A company that sold the product and walked away will be starting from zero. Pull out the warranty terms on you best-selling product. Does it assume the product will be thrown away and replaced, or does it assume someone, possibly your own company, will still be paying for what happens to it five years from now? The labour moves from the factory floor to the field Social Michelin launched a program called EFFIFUEL [4] in 2013 for trucking fleets. The company sells more than tires under this program. It audits the fleet, installs monitoring equipment, and trains drivers in fuel-efficient driving. If the fleet hits the agreed fuel savings target, both sides share the gain. If misses the target, Michelin refunds part of the cost. The result after the first year: fuel savings of 1.5 litres per 100 kilometres per truck. Say like this, it sound modest, but run it across a fleet doing 120,000 kilometres a year and it adds up to real money. The savings came from training, not from a new tire compound. A person behind the wheel had to change habits, and someone had to teach them how. That is the social pillar in practice. A service model more than machines. It moves jobs. It creates work for driving coach, the fleet auditor, the technician who checks the equipment. Those are not glamorous jobs. They are jobs that exist because the seller now has a financial reason to make sure the product performs well in someone else's hands, for years, long after the day it left the factory. Photo by Enis Yavuz on Unsplash Textile carries the same logic. The Dutch denim brand MUD Jeans launched Lease a Jean in 2013. A customer pays a monthly fee for a pair of jeans instead of buying them outright, gets them repairs and after twelve months keeps the jeans or send them back to be recycled into new pair. A pair made this way uses roughly 400 litres of water against an industry average of nearly 7,000 litres and produces about 3.4kg of CO2e against an industry average of 23. Jeans The model almost died [5] three years after launch, because the administrative work behind it (tracking who holds which pair, when each lease ends, what condition a returned pair is in), happened to eb harder to run than the company expected. Selling a product once and shipping it out is simple. Staying the owner for the product's whole life cycle is an operation problem, before it is a sustainability story. MUD brought the model back a few months later because customers kept asking for it, and about half its customers now lease rather than buy. The risk finds its way back to whoever made the promise Governance Rolls-Royce, or rather its predecessor Bristol Siddeley, built the original version of the model Product as a Service in 1962. The program named Power by the Hour, covered the Viper jet engine on the Havilland 125 business jet. Viper jet Airlines paid a fixed rate per flying hour, and that single fee covered a full engine and accessory replacement service, so the operator only paid for an engine that worked. Rolls-Royce absorbed Bristol Siddeley in 1966 and kept the model. The current version is called TotalCare.[6] An airline still pays a fixed rate per flying hour. Rolls-Royce still covers the maintenance. What changed is the data behind it: thousands of sensor readings per flight now feed Rolls-Royce's own monitoring centre, so a shop visit gets scheduled before a part fails rather than after. For years this looked like a clean win for manufacturer, since better-performing engines meant lower service costs and higher margin. Then came Trent 1000 a specific jet engine built exclusively for the Boeing 787 Dreamliner. Starting in 2016, cracking showed up in the turbine blades of the engine. Airlines grounded aircraft. Regulators shortened how far those planes could fly from nearest airport. By 2019, Rolls-Royce had to pay more than 2.4 billion pounds in costs tied to fixing the problem [7], a figure that later went up to 3 billion. The company had an operating loss the same year, the crisis picked. Bristol Siddeley's 1962 version proved the principle, if it doesn't work, you don't get paid. The Trent 1000 crisis proved the principle at a scale where "you don't get paid" turned into "you pay to keep your customers flying, you pay to fix the design, and you pay for years, not weeks." Same logic, but the bill for that logic scales with how many planes are in the sky and how long they've been broken. That is governance stripped down to its bones. In ESG sense, governance means the apparatus: board committees, audit trails, disclosure requirements, whistle-blowers systems, third party reviewers. All of that machinery exists for one purpose: Accountability. The goal is to force someone to answer for a risk they created, especially when their instinct would be to avoid answering for it. Committees, audits and reports are the scaffolding built around that purpose because accountability does not happen automatically in most companies. TotalCare reaches that same purpose without any of the scaffolding. Rolls-Royce designed the turbine blade. Rolls-Royce is also the party whose bank account takes the hit the moment that blade cracks. There is no distance between the decision and the consequence for anyone to exploit. No annual report cycle where the problem can get buried, no committee that has to first discover the issue before anyone acts on it. The contract itself makes the responsible party the paying party, instantly and automatically, the day the flaw shows up in the real world. Incentive alignment forces accountability faster than reporting requirements do. None of that makes the model the villain of this story. A design flaw in the turbine blades caused the crack, one that existed the moment the engine left the drawing board, years before TotalCare had anything to do with it. Sell that same engine outright and the flaw does not disappear. It still shows up, on the airline's maintenance bill instead of Rolls-Royce's balance sheet, spread across years of warranty disputes and quiet part replacements the public never hears about. TotalCare did not create the 2.4 billion pound bill. It moved that bill onto the one balance sheet with both the knowledge and the means to fix the problem at the source, and it moved it there in months instead of over a decade of buried claims. That is the real lesson about the model "product as a service". A service model does not forgive weak engineering? It exposes it faster. A company weighing a move to product as a service needs its durability testing, failure analysis, and quality assurance built to match the incentive it is about to take on, because the contract will find any gap between what was promised and what was built, faster than you think. Rolls-Royce mistake was never signing TotalCare. It was signing it before they could carry what they promised. Fix the engineering to the standard the contract demands, and TotalCare does exactly what it is supposed to do: pay for a problem before it becomes someone else's emergency at 30,000 feet. TotalCare did not disappear after this crisis. It expanded. In Februrary 2026, China Airlines signed a TotalCare agreement covering 36 Trent XWB engines for its A350 fleet [8], one of a string of new agreements Rolls-Royce has closed with airlines from Ethiopian to Kuwait Airways since the crisis peaked. Rolls Royce now describes TotalCare on its website as "a circular business model, built to close the loop on material use and cut waste". The Trent 1000 is still flying, stil covered under TotalCare, and still being upgraded. The Digital product Passport works on the same logic from the regulatory side. It does not ask a company to promise good behaviour. It asks for a record that get checked. A company already running a service model has that record because it needs it to keep the contract alive. A company that only ever sold the product and moved on will be building that record for the first time, under a deadline it did not choose. Textile companies built a version of this record decades before regulation asked for one. Workwear providers such as Lindström, Mewa, Elis, and CWS Workwear do not sell uniforms to factories, hospitals, and hotels. They rent them, wash them, repair them, and take them back at the end of their working life. Lindström has run this model for close to a century and now operates in 24 countries. Every garment carries an RFID tag that logs how often it has been worn, washed, and repaired, a private-sector audit trail built for operational reasons, long before any regulator asked for one. Even a model this proven hits a wall that has nothing to do with logistics. When Lindström expanded into Asia [9], the barrier was not technical. Buyers there associate ownership with trust and see rented or shared textiles as a hygiene risk, regardless of how well the laundering performs. A traceable, audited, decades-tested system still had to fight a belief before it could fight a cost. Could your company produce, this week, a record of what happens to your product after it leaves the warehouse? Or would that take six weeks and an outside consultant to reconstruct after the fact? The gap between those two answers is the gap the Digital Product Passport is about to make public. Conclusion Circular Economy has been presented as the answer for decades. Upcycle it. Downcycle it. Close the loop. Call it solved. As a physical chemist, the flaw in that promise was visible to me from the start. A upcycled or downcycled product still ends in a landfill or an incinerator. Circularity does not remove the waste. It postpones it, sometimes by years, sometimes by one cycle, and calls the delay a victory. The real fix sits earlier than recycling. Produce less. Build it to last. That is sustainability by design, and it does not happen because a company writes it into a mission statement. It happens when the seller pays for every unit that fails, breaks, or gets thrown away. Product as a service is not a nicer way to sell things. It is the pricing structure that forces sustainability by design to happen, because the company eating the waste is now the same company deciding how the product gets built. Companies keep reporting sustainability as a value statement. The evidence points somewhere else. It points to a pricing structure. Sell the outcome instead of the object, and the waste, the training, and the accountability all move to whoever is left holding the risk. Get that structure right and a company stops managing waste and starts producing less of it. That is not a philosophy. It is a contract, and it is the closest thing to sustainability by design that a pricing model has ever produced. [1] https://www.signify.com/global/signify-services/managed-services/light-as-a-service [2] https://spain.arcelormittal.com/que-hacemos/productos-planos/sagunto/ [3] https://eur-lex.europa.eu/EN/legal-content/summary/ecodesign-requirements-for-sustainable-products.html [4] https://www.tirereview.com/new-michelin-solutions-division-launches-with-effifuel/ [5] https://www.retaildetail.eu/news/fashion/mud-jeans-is-discontinuing-its-pioneering-circular-leasing-model/ [6] https://www.rolls-royce.com/media/our-stories/discover/2017/totalcare.aspx [7] https://www.cnbc.com/2019/11/07/rolls-royce-takes-another-1-billion-hit-to-fix-problem-engine.html [8] https://www.rolls-royce.com/media/press-releases/2026/04-02-2026-rr-signs-totalcare-agreements-with-china-airlines-for-36-trent-xwb-engines.aspx [9] https://www.imd.org/ibyimd/industry/industrials/weaving-new-threads-how-lindstrom-is-reframing-circular-workwear-in-asia/

How Dr. Audrey-Flore Ngomsik is Proving That Sustainability Can Be Profitable An article written by Women Who Build Africa to highlight Dr. Ngomsik's mission and vision for Africa. Trianon Scientific communication Introduction: The Intersection of Profit and Sustainability Sustainability is often seen as a cost. But what if I told you it could be a profit center? Dr. Audrey-Flore Ngomsik is here to change that narrative. She is a beacon of hope in the sustainability sector. Her work demonstrates that sustainable practices can lead to significant financial gains. The Vision of Dr. Ngomsik Dr. Ngomsik envisions a future where businesses thrive while being environmentally responsible. She believes that sustainability is not just a buzzword; it’s a necessity. In her view, the future of business lies in embracing sustainable practices. This is not just about compliance; it’s about innovation and leadership. The Profitability of Sustainability How can sustainability be profitable? The answer lies in efficiency. By adopting sustainable practices, companies can reduce waste and lower operational costs. This is where Dr. Ngomsik shines. She provides actionable strategies that lead to both environmental and financial benefits. Imagine cutting down on energy costs while also reducing your carbon footprint. Sounds appealing, right? Dr. Ngomsik has proven that these aren’t just dreams; they can be realities for businesses willing to adapt. Case Studies: Success Stories Dr. Ngomsik has worked with various organizations, transforming their sustainability strategies. One notable example is a chemical company that faced rising costs due to inefficient processes. After implementing Dr. Ngomsik's recommendations, they not only reduced waste but also saw a 20% increase in profits. These success stories are not isolated. They serve as a testament to the power of sustainable practices. Companies that embrace sustainability can gain a competitive edge. They can attract customers who prioritize environmentally friendly products. The Role of Education in Sustainability Education plays a crucial role in this transformation. Dr. Ngomsik emphasizes the need for training and awareness. It’s not enough to implement changes; everyone in the organization must understand the importance of sustainability. This is where Trianon Scientific Communication comes into play. We aim to become the go-to expert for companies struggling with sustainability strategies that hurt their bottom line. We help them transform these challenges into significant profit increases and sustained competitive advantage. Overcoming Challenges Transitioning to sustainable practices is not without its challenges. Resistance to change is common. However, Dr. Ngomsik encourages businesses to view these challenges as opportunities. By fostering a culture of innovation, companies can overcome obstacles. They can turn sustainability into a core value rather than a compliance issue. This shift in mindset is crucial for long-term success. Conclusion: The Future is Sustainable In conclusion, Dr. Audrey-Flore Ngomsik is proving that sustainability can be profitable. Her work inspires businesses to rethink their strategies. By embracing sustainability, companies can achieve financial success while contributing to a healthier planet. Are you ready to join the movement? The time for change is now. Let’s make sustainability a priority and watch profits soar. For more insights, check out Dr. Audrey-Flore Ngomsik's spotlight. --- This is just the beginning. The conversation around sustainability is evolving. Let’s be part of that evolution together.

Chernobyl disaster The Chernobyl disaster serves as a stark reminder of the consequences of poor governance. The reactor exploded because the governance structure made telling the truth more dangerous than running the reactor. Two engineers flagged the test as unsafe, but they were dismissed. The reactor ran anyway. Your board is doing the same thing with AI. Not because you are reckless, but because no one has asked the four critical questions that matter: The Four Critical Questions What is the environmental liability of your AI footprint? Has anyone calculated it? Who has the technical authority to stop an AI decision heading in the wrong direction? What are your agents authorized to do right now, without human review? What happens when one of them is wrong? These questions are not just theoretical. They are urgent. The EU AI Act deadline is August 2, 2026. This means personal liability for board members and potential fines of €35 million. That’s just 97 days from today. Are you prepared? The Consequences of Inaction The board that approved the April 25 test at Chernobyl is not around to answer for it. The board approving your AI strategy today will be. What legacy will you leave behind? Will you be remembered for your foresight or your negligence? The Cost of Ignorance Ignoring these questions can lead to devastating consequences. Just like the Chernobyl disaster, the fallout from poor AI governance can be catastrophic. It’s not just about compliance; it’s about survival. Your company’s reputation, financial stability, and even its existence could be at stake. The Path Forward So, what can you do? Start by fostering a culture of transparency. Encourage open discussions about the risks associated with AI. Bring in experts who can provide insights into the environmental impact of your AI initiatives. Don’t wait for a disaster to strike. Take proactive steps now to ensure that your AI governance is robust and effective. Embrace Sustainability Sustainability is not just a buzzword; it’s a business imperative. Companies that prioritize sustainable practices often see significant profit increases and a sustained competitive advantage. By addressing the environmental liability of your AI footprint, you can transform challenges into opportunities. Are you ready to make a change? The time to act is now. Conclusion In conclusion, the lessons from Chernobyl are clear. We must prioritize governance in our AI strategies. The stakes are high, and the time for action is now. Don’t let history repeat itself. Embrace the challenge of sustainable AI and turn it into your competitive advantage. What will your board choose? Will you lead with courage and foresight, or will you let fear dictate your decisions? The choice is yours.

Why This Vote on Crop Gene Editing Happened Environmental Sustainability NGT-1 crops are marketed as requiring less water, fewer pesticides, and less fertilizer. These are exactly the inputs Europe aims to reduce under its climate targets. With faster drought and disease resistance, these crops promise fewer failures as growing seasons become less predictable. The European Commission has been building this case since 2021, linking NGTs to the European Green Deal. Social Sustainability EU tillage and grain farmers have faced rising input costs, shrinking direct payments, and a dwindling list of approved plant protection products. The argument is that faster breeding can deliver resilient varieties to farmers sooner. This prevents them from relying on outdated tools from the 1990s during challenging seasons. Economic Sustainability Countries like the US, China, and those in South America have had more permissive gene-editing rules for years. The EU's approval process has lagged behind, creating a competitiveness cost. Eight years of legislative back-and-forth on this issue has frustrated many agricultural groups that pushed for this vote. The Wrong Argument Everyone Is Having The debate centers around safety, but that's the wrong question. The right one is: who decided that 20 genetic modifications is the pass mark? The Scientific Debate Brussels Used to Justify the Vote Detlef Weigel from Max Planck states that if a CRISPR-edited plant has no foreign DNA and only changes that could occur naturally, there’s no scientific reason to regulate it like a transgenic GMO. Detlef Weigel Conversely, Michael Antoniou from King's College London argues that the CRISPR editing process can cause large-scale, unintended changes to the plant's DNA, sometimes affecting hundreds or thousands of sites. A mutation count of 20 does not capture this complexity. Dr. Michael Antoniou Two scientists, two credible positions. Yet, the EU has set a pass mark of 20 modifications, creating a false sense of clarity. The Question Nobody Is Naming The environmental, social, and economic arguments led Brussels to drop traceability and labeling. None of these arguments required Brussels to address preventability. NGT crops can still be patented. Critics argue this favors large corporations like Bayer, Syngenta, and Corteva over small and medium enterprises (SMEs) and farmer cooperatives that cannot absorb these costs. Here’s the crucial question: Do faster climate adaptation, food security, and competitiveness truly require a patent regime? If urgency was genuine and the patent issue separate, why were both passed in the same vote? It’s ironic how this aligns perfectly with the interests of a few large companies while leaving smaller cooperatives at a disadvantage. The Pattern We See on Boards This situation reflects a governance failure disguised as a scientific debate. We often see this pattern. A board approves a strategy based on a seemingly rigorous number—20 modifications, 73% circularity, net zero by 2040—without questioning the underlying assumptions. If you’ve written a sustainability strategy for your board this year, identify your version of 20 modifications. Every strategy has one. It’s the threshold everyone accepted because it had a number, not because anyone examined what that number truly represented. How This Gets Done Right Grade the Outcome, Not the Pass Mark We should require genomic profiling pre-market, as Antoniou suggests, and make the results public. This approach combines Weigel's precision argument with Antoniou's safety argument, rather than relying on a single number that oversimplifies the issue. Separate the Urgency Case from the Ownership Case Fast-track approval for traits that genuinely contribute to environmental sustainability, food security, or competitiveness—like drought tolerance and pest resistance. However, do not fast-track patent rights in the same vote. If the goal is truly about industrial policy, it deserves a separate, thorough debate. Price the Asymmetry A small seed cooperative and Bayer do not face the same patent costs, even when both are addressing the same climate problem. If your regulations don’t account for this disparity, you haven’t accelerated climate adaptation; you’ve merely consolidated the market and handed diplomas to the same few. Where This Leaves Boards This is what we do for boards before the vote, not after the headlines. We identify the hidden pass marks in strategies and question their origins. What were they built to avoid measuring? Then we assess the costs involved. If your sustainability or innovation strategy has a number like this embedded within it, you already know the one we’re discussing. Start there. 1] [CRISPR: Gene Editing for Crops—Precision Tool or New Risk? 2] [European Commission Study on New Genomic Techniques 3] [EU Backs New Gene-Edited Crop Rules Despite Opposition 4] [What Will Change with the New GMO Law in Europe?

Corporate Social Responsibility (CSR) is no longer a side note in business. It’s a critical driver of success. But how do you create CSR strategies that truly make an impact online? How do you ensure your efforts resonate, engage, and deliver measurable results? The answer lies in mastering the art of online CSR strategies that are bold, authentic, and actionable. You might be wondering: Isn’t CSR just about doing good? Yes, but it’s also about doing well by doing good. It’s about transforming sustainability challenges into profit opportunities. If you’re ready to stop playing catch-up and start leading, this post is your blueprint. Why Online CSR Strategies Are Non-Negotiable Today The digital world is where your audience lives, breathes, and interacts. Ignoring this space means missing out on massive opportunities to amplify your CSR impact. But it’s not just about presence; it’s about purposeful presence. Think about it. How many companies post CSR reports once a year and call it a day? That’s not enough. Your CSR efforts must be visible, transparent, and engaging online. This is where trust is built and reputations are made or broken. Online CSR strategies allow you to: Reach a global audience instantly Engage stakeholders in real-time conversations Showcase measurable impact with data and stories Build a community around your values If you’re in sectors like pharmaceutical, chemical, agro-food, textile, cosmetics, materials, or energy, your CSR footprint matters more than ever. These industries face intense scrutiny. Your online CSR strategy can be your shield and your sword. Crafting Online CSR Strategies That Deliver Real Results Creating impactful CSR strategies online is not guesswork. It requires precision, planning, and passion. Here’s how to get it right: 1. Define Clear, Measurable Goals What does success look like for your CSR efforts? Is it reducing carbon emissions by 20%? Supporting 1,000 local farmers? Increasing employee volunteer hours? Set specific, measurable, achievable, relevant, and time-bound (SMART) goals. 2. Know Your Audience Inside Out Who are you talking to? Investors? Customers? Local communities? Each group cares about different aspects of CSR. Tailor your messaging and channels accordingly. Use social media analytics, surveys, and feedback loops to refine your approach. 3. Leverage Storytelling and Transparency Numbers tell part of the story, but stories move hearts and minds. Share real-life examples of how your CSR initiatives change lives or protect the environment. Be transparent about challenges and setbacks. Authenticity builds trust. 4. Use Digital Tools to Amplify Impact From interactive dashboards to virtual events, digital tools can make your CSR efforts more engaging. Consider: Live-streaming community projects Creating infographics and videos Hosting webinars on sustainability topics 5. Collaborate and Co-Create Partner with NGOs, local governments, and even competitors to scale your impact. Online platforms make collaboration easier than ever. Joint campaigns can multiply reach and credibility. 6. Monitor, Measure, and Adapt Use KPIs and analytics to track progress. What’s working? What’s not? Be ready to pivot. Continuous improvement is the hallmark of successful CSR. Remember, online csr strategy development is a dynamic process. It’s not a one-time setup but an ongoing journey. The Role of Technology in Online CSR Strategies Technology is the engine driving modern CSR. It’s not just about automation or data collection. It’s about creating immersive, interactive experiences that connect people to your mission. Imagine virtual reality tours of your sustainable farms or AI-powered platforms that match employee skills with volunteer opportunities. These innovations make CSR tangible and exciting. Moreover, blockchain technology can enhance transparency by providing immutable records of your CSR activities. This builds confidence among stakeholders who demand accountability. Don’t underestimate the power of mobile apps either. They can engage employees and customers alike, turning CSR into a daily habit rather than a quarterly report. Overcoming Common Challenges in Online CSR Strategy Development Let’s be honest. Developing impactful online CSR strategies is not without hurdles. You might face: Resource constraints: Limited budgets or staff can stall initiatives. Data overload: Too much information without clear insights. Stakeholder skepticism: Doubts about sincerity or impact. Regulatory complexities: Navigating compliance in multiple regions. How do you tackle these? Start by prioritizing initiatives that align with your core business and values. Use data analytics tools to filter and focus on key metrics. Communicate openly to build trust and invite feedback. And stay informed about legal requirements to avoid pitfalls. Remember, every challenge is an opportunity to innovate and differentiate. Taking Your Online CSR Strategy to the Next Level You’ve laid the groundwork. You’ve engaged your audience. Now, how do you scale and sustain your impact? Integrate CSR into your brand DNA: Make it part of your company culture and decision-making. Empower employees as CSR ambassadors: Encourage them to share their stories and ideas. Invest in continuous learning: Stay ahead of trends and best practices. Celebrate and publicize successes: Recognition fuels momentum. By doing this, you don’t just comply with expectations—you exceed them. You turn CSR from a cost center into a competitive advantage that drives growth and loyalty. If you want to dive deeper into effective online csr strategy development, explore resources and expert guidance tailored to your industry and goals. Creating impactful online CSR strategies is not optional anymore. It’s urgent. It’s essential. It’s your pathway to a sustainable, profitable future. Are you ready to lead the change?

We were not looking for this. We were doing research on something else entirely when I landed on an article by the Association for Asian Studies titled "Teaching about the Comfort Women during World War II and the Use of Personal Stories of the Victims." The article describes the comfort women system as the largest case of government-sponsored human trafficking and sexual slavery in modern history, created and controlled by the Imperial Japanese government between 1932 and 1945.[1] Then I read Yong Soo Lee's testimony. Taken from her home in Korea at sixteen. Transported across three countries in cargo ships. Forced to serve soldiers daily. Warned her family would be killed if she spoke. Then Jan O'Herne. Dutch, twenty-one years old, selected from a prison camp lineup by officers who walked the row and pointed. Returned three months later with a threat sewn into her silence. Then I stopped reading and started thinking about the pattern. Korean comfort women who survived and where in Lamang (1945) Wartime rape as a governance failure The scale of a crime that never stopped 200,000 women. That is the documented minimum for the Japanese "comfort women" system alone. They were forced into sexual slavery by the Imperial Japanese Armed Forces across occupied territories before and during World War II. The word "comfort" was chosen deliberately. Someone in a leadership position chose that word.[2] That tells you everything about how power relates to this crime. Rape during wartime is an act as old as war itself. It was not documented as a strategic military practice until World War I. After World War I, these crimes were never prosecuted, which further encouraged the use of mass rape as a strategic military operation in subsequent conflicts.[3] It did not stop. Between 250,000 and 500,000 women were raped in just three months in Rwanda in 1994. More than 200,000 are estimated to have been raped in Sierra Leone during the 1990s. Hundreds of thousands of women were violated in the DRC's 20-year war.[4] In Bosnia, systematic rape was used as part of a strategy of ethnic cleansing. Women were raped specifically so they would give birth to a Serbian baby.[5] Rape as policy This is not violence that happens alongside war. One of the most significant shifts in current thinking is the recognition that rape in wartime is not a by-product of war, but often a planned and targeted policy.[6] It is a governance decision. When you plan it, resource it, and command it through a military chain of authority, it is policy. And policy reflects the values of those who set it. The accountability that never came Now ask the harder question. What does it say about the leaders of these countries when the crime is documented, the perpetrators are known, and accountability still fails to arrive? The rapes admitted and listed as war crimes were dismissed during the Nuremberg trials, probably because they were also practiced by Allied armies.[7] U.S. servicemen committed an estimated 3,500 rapes in France between June 1944 and the end of the war. These were the liberators. A local saying from Normandy survived because it is precise: "With the Germans, the men had to camouflage themselves. With the Americans, we had to hide the women."[8] The command structure knew. Eisenhower received a formal complaint from the Free French Forces. He issued orders. The rapes continued. Of the 152 troops charged with rape by the Army in France, 139 were African American. Of the 29 soldiers executed for rape, 25 were African American. In a country where Black soldiers were systematically excluded from combat units, leadership roles, and military honors, they were suddenly overrepresented in rape convictions. The crime was not being prosecuted. Specific bodies were being sacrificed to protect the narrative of liberation. That is a governance decision. Colonialism used the same weapon In the Belgian Congo, rape, sexual exploitation and torture of native women were used as punishment, extortion, and a display of colonial power. Brutality and intimacy were basic to colonialism itself.[9] Belgian colonial officials and their sentries employed rape and sexual torture on a massive scale during the rubber regime of King Leopold II. Contemporary international discourse on conflict-related sexual violence in eastern DRC is marked by its complete omission of this history.[10] The omission is structural. When a country's leaders refuse accountability for this crime, they are not protecting soldiers but the architecture that made the crime possible: the chain of command, the ideology, the institutional silence. Who decides which suffering counts Japan's conservative political establishment spent decades insisting comfort women were voluntary. Controversies over comfort women statues and Japanese history textbooks continue. Conservatives insist that comfort women were voluntary prostitutes. The ongoing efforts to secure justice underscore the unending battle against stigma toward survivors.[11] I call that an active governance of whose suffering counts. Leadership boards that are 90% male and homogeneous do not just miss market risk. They miss which crimes get named, which victims get compensated, and which atrocities get written out of the textbooks their children read. Boards do not fail on diversity metrics. They fail on the decisions that homogeneity made invisible. The question every board member, every policy maker, and every government minister should be asked is not "did you commit the crime?" The question is: who decided it did not count? Because someone always decides that. And that someone is always in a leadership position. The oldest materiality assessment there is In CSR, we call it materiality assessment. You decide which risks are significant enough to report, to manage, to price. The comfort women were a materiality decision. The rapes in Normandy were a materiality decision. Colonial sexual violence was a materiality decision. Every time a leadership body decides that a category of harm does not count, it is performing the same calculation that modern boards perform when they exclude social risk from their balance sheets. The mechanism is identical. Only the language has changed. At Trianon, we have argued for years that separating the Ministry of Ecology from the Ministry of Foreign Affairs is itself a governance failure. Environmental destruction does not stop at borders. Sexual violence in conflict zones is inseparable from the collapse of ecosystems, the competition for land and water, and the economic desperation that armed groups exploit. A ministry that manages climate and a ministry that manages conflict should not be producing separate reports, separate budgets, and separate accountability frameworks for what is, structurally, the same problem. The women in this article were not harmed by isolated actors. They were harmed by systems. Governing systems requires seeing them whole. Documented reports of sexual violence exist in several active conflicts today. Ukraine, Gaza, Sudan, the Democratic Republic of the Congo, Myanmar, Syria, Somalia, South Sudan, Haiti, and the Central African Republic are all covered in the UN Secretary-General's most recent annual report on conflict-related sexual violence. The UN recorded nearly 10,000 cases of conflict-related sexual violence worldwide in 2025 alone, more than double the previous year's figure. In Sudan, two-thirds of women frontline responders reported a significant increase in sexual violence in 2025, with half reporting further escalation into 2026. We have not included any of them here. Not because the evidence is absent, but because all of these conflicts are active, politically contested at every level of documentation, and subject to ongoing legal proceedings. Writing about them in this format, without the investigative depth they require, would reduce living women to rhetorical ammunition. The historical cases in this article are documented, adjudicated, and in most instances officially acknowledged. They are not less serious for being past. They are simply less likely to be weaponized by readers looking for confirmation of a geopolitical position rather than an honest reckoning with how power operates. That distinction matters to me. [1] https://www.asianstudies.org/publications/eaa/archives/teaching-about-the-comfort-women-during-world-war-ii-and-the-use-of-personal-stories-of-the-victims/ [2] https://en.wikipedia.org/wiki/Comfort_women [3] https://www.sciencedirect.com/science/article/abs/pii/S0277539509000843 [4] https://www.ibtimes.co.uk/mass-rape-weapon-war-bosnia-verdict-warning-leaders-who-unbolt-heart-darkness-1551989 [5] https://www.msf.org/rape-weapon-war [6] https://link.springer.com/article/10.1007/s10691-009-9118-5 [7] https://ehne.fr/en/node/12512/printable/print [8] https://en.wikipedia.org/wiki/Rape_during_the_liberation_of_France [9] https://blogs.lse.ac.uk/africaatlse/2018/07/18/when-archives-speak-back-sexual-violence-in-the-congo-free-state/ [10] https://www.researchgate.net/publication/308126691_Sexual_Violence_in_the_Congo_Free_State_Archival_Traces_and_Present_Reconfigurations [11] https://humanwrites.umn.edu/nanjings-women-sudans-survivors-ending-rape-weapon-war

International Women’s Day focus: The patient was never me. But it might be you pubished in the Bulletin.be on March 8th, 2026

We spent two years as external consultants watching companies hire managers and directors. They paid us to improve their processes. What we saw was a masterclass in how bias disguises itself as professional judgment. Same credentials on paper. Wildly different outcomes in practice. Here’s what nobody wants to admit. Names have been changed to protect confidentiality, but the patterns are real. The First Pattern: Ethnicity Naomi and Corinne interviewed for the same director role. Same MBA from INSEAD. Same 15 years in finance. Same track record. Corinne walked in. Questions on strategic vision, risk management, industry network. Someone mentioned Verbier. Ten minutes bonding over ski resorts. The conversation flowed. Two weeks later, offer. Picture from unsplash.com Naomi walked in. Different questions appeared. “How do you handle conflict?” “Do you think you’ll fit with our culture?” “Can you work with strong personalities?” Translation: Can you deal with being the only Black woman in the room without making us uncomfortable? She gave the same answers Corinne gave. Cited research. Showed regulatory foresight expertise. No one mentioned Verbier. No one bonded. Three weeks later, email. “We’ve decided to go with someone who’s a better cultural fit.” Here’s where it gets interesting. The job posting said they valued “diverse perspectives” and “challenging the status quo.” Corinne’s innovation answer: “We should look at what our competitors are doing and identify best practices.” Naomi’s innovation answer: “Your competitors are copying each other. The regulatory landscape is shifting faster than your industry is adapting. Here’s where the gaps are.” The role’s stated priority: “Preparing the organization for regulatory changes in sustainability.” Corinne’s experience: Traditional finance. Strong on quarterly reporting. Naomi’s experience: Led three companies through major regulatory transitions. Has relationships with policymakers. Knows what’s coming before it hits the news. Guess who they called a “culture fit”? Picture generated by nano banana (AI) They said they wanted fresh thinking. Corinne suggested what they’re already doing. Naomi suggested what they’re not ready to hear. They hired Corinne. Six months later, they got blindsided by exactly the regulatory changes Naomi had flagged. What does “culture fit” actually mean when the person who fits your culture can’t see the risks the outlier spotted immediately? The Second Pattern: Ethnicity Meets Gender Same type of organization. Different director role. Claudia and Pierre. Same credentials. Same MBA, same experience, same track record. Pierre mentioned golf. Three hiring managers play golf. Ten minutes talking courses. When he spoke, they leaned in. Bold suggestion? “Strategic thinking.” One week later, offer. Picture from unsplash.com Claudia got the same questions as Noami’s before. Conflict handling. Culture fit. We watched them glance at each other. Silent communication excluding her. Three weeks later, same email. “Better cultural fit.” Picture generated by Freepik (AI) For every 100 men promoted to management, only 58 Black women get the same shot (1). Black women account for 1.4% of C-suite executives. White men hold 68% (1). When there’s only one diverse candidate in the finalist pool, they have statistically zero chance of being hired (1). The hiring committee congratulated itself on interviewing a diverse slate. What they gave Naomi was extra hoops that don’t exist for Pierre. Then they called it merit. The Third Pattern: Gender Alone Different organization. Manager position. Corinne and Pierre. Same credentials. Same interview questions. Jean spoke with confidence. They leaned in. Corinne spoke with the same confidence. We watched them shift in their seats. Jean made a bold suggestion. “Strategic thinking.” Corinne made the same suggestion. “Aggressive.” Someone asked Corinne: “This role requires significant travel. How will you manage that?” Jean never got that question. Two weeks later, email. “You’re talented, but we’re looking for someone with more executive presence.” The double blind became clear. They wanted “strong leadership.” Jean was direct. “Decisive.” Corinne was direct. “Difficult.” They valued “collaborative approach.” Jean built consensus. “Natural leader.” Corinne built consensus. “Lacks authority.” Identical CVs receive different ratings based on gender. Male candidates rated as more competent and hireable (2). A 2025 meta-analysis of 243,202 job applications confirmed systematic discrimination against women in male-dominated fields (and also confirmed the ethnicity bias) (3). Same words. Different reactions. Jean’s confidence was “executive presence.” Corinne’s confidence was “not quite right for the culture.” Picture from unsplash.com What “Culture Fit” Actually Costs We watched this pattern repeat for two years. “Culture fit” is code for comfort. Research from Northwestern’s Kellogg School found that when interviewers said they “clicked” with a candidate, they meant similar background. Same sports, same schools, same vacation spots (4). Then they dressed it up as professional judgment. Research shows that non white women believe executive presence is defined by conforming to white male standards (5), with 56% of non white people reporting they're held to higher standards than white colleagues in demonstrating executive presence (6). Women receive less quality performance feedback than men. Evaluations focus on personality traits instead of specific accomplishments (7). The “think manager, think male” phenomenon means masculine traits are associated with leadership more than feminine traits (7). These aren’t bad people making these decisions. They’re good people operating in a system designed to make bias look like merit. The Real Cost Every hiring committee we observed claimed they wanted innovation. Fresh perspectives. Someone who could help them anticipate change. Then they hired the person who reinforced what they already thought. Naomi told them where the regulatory risks were. They hired Corinne. Six months later, blindsided. Corinne gave them the same strategic recommendation as Pierre. They hired Pierre. Called him visionary. The candidates who delivered what the committees said they wanted got rejected for not fitting the culture. The candidates who reflected the existing culture back got hired. Then the organizations wondered why they kept making the same decisions. Missing the same risks. Getting caught off guard by changes they claimed they wanted to anticipate. Here’s what that pattern recognition costs them. When you reject the outlier who spots the risks comfortable insiders never see, you’re not excluding diversity. You’re excluding your early warning system. The invisible work isn’t just the extra prep Naomi and Corinne did before interviews. It’s knowing they’ll do it again at the next role. And the next one. And the next one. It’s watching less qualified candidates walk in and get assumed competent while you prove yourself despite identical credentials. It’s being told you’re “talented” but not quite right while watching someone with your exact background get called “executive material.” Why This Matters We went into this work expecting to see bias. We’ve read the research. We know the data. What surprised me was how invisible it was to the people doing it. No one in these rooms thought they were discriminating. They thought they were assessing culture fit. They thought they were evaluating executive presence. They thought they were making objective decisions about who would be best for the role. They were wrong. But the system is designed to make that wrongness look like rightness. After two years of watching this play out, here’s what we know. The game is rigged to look fair. Organizations will keep hiring comfort and calling it competence until they’re willing to examine what “culture fit” actually means in practice. They’ll keep missing the perspectives they claim to want. They’ll keep getting blindsided by risks they could have anticipated. They’ll keep congratulating themselves on their commitment to diversity while rejecting the diverse candidates who actually show up. What does it cost to hire someone who makes you comfortable instead of someone who makes you think? Ask the companies that got blindsided by the exact risks their rejected candidates flagged. They’re still calling it merit. Why We Can Help Fix This Dr Audrey-Flore Ngomsik, our co-founder, is one of statistical anomalies these hiring committees reject. Black woman. Physical & Analytical Chemistry PhD. Brussels Climate Committee VP. Multi board director. We got into these rooms by asking questions other people were afraid to ask. Then we built a methodology that turns uncomfortable truths into profit increases. For two years, we watched companies pay us to observe their hiring processes while systematically rejecting candidates who looked like Dr Ngomsik. Candidates with better qualifications. Candidates who spotted risks the “culture fits” missed. Those same companies now wonder why they keep getting blindsided by regulatory changes, market shifts, and systemic risks. Here’s what we learned: The pattern recognition that makes someone “not quite right for the culture” is exactly what spots the problems comfortable consensus misses. We work with organizations that are ready to examine what “culture fit” actually costs them. Not in moral terms. In economic terms. Because when you hire comfort over competence, you don’t just lose diverse candidates. You lose your early warning system. Trianon Scientific Communication , has helped companies increase profits by 60-80% by redesigning strategies around economic reality instead of comfortable assumptions. We start with the questions your organization has been avoiding. Then we build frameworks that work. Not every company is ready for that conversation. But the ones that are don’t stay blind to risks their competitors keep missing. If you want to examine what your hiring patterns are actually costing you, we answer provocative questions with data, not hope. (1) Lean In & McKinsey (2020). The State of Black Women in Corporate America . (2) Inside Higher Ed (2019). New study finds discrimination against women and racial minorities in hiring in the sciences . (3) Park, S.Y. & Oh, E. (2025). Getting a Foot in the Door: A Meta-Analysis of U.S. Audit Studies of Gender Bias in Hiring. Sociological Science. (4) Rivera, L. (2022). Stop Hiring for "Cultural Fit." Kellogg Insight. (5) Executive Leadership Council (2021). "Creating Standards of Leadership and Professionalism Rooted in Blackness." ELC Magazine, Winter 2021. (6) Hewlett, S.A. (2014). "Cracking the Code That Stalls People of Color." Harvard Business Review, March-April 2014 issue. (7) Catalyst (2024). Black women still face a glass cliff, but fixing workplace systems can change that.

Who Decided This Was Safe?